Search Results - "Morineau, P."

Measles seroprevalence in human immunodeficiency virus-infected adults born in the era of measles vaccination by Lefebvre, Maeva, Secher, Solène, Bouchez, Sabelline, Vandamme, Yves-Marie, Fialaire, Pascale, Leautez, Sophie, Blanchi, Sophie, Michau, Christophe, Coste-Burel, Marianne, Brunet-Cartier, Cécile, Reliquet, Véronique, Gregoire, Antoine, Raffi, François, Allavena, Clotilde

“…Widespread use of the measles vaccine should lead to the elimination of this disease. Here we study the seroprevalence of measles in a cohort of adults living…”
Get full text

Efficacy and safety of dolutegravir and rilpivirine dual therapy as a simplification strategy: a cohort study by Gantner, P, Pugliese, P, Bani‐Sadr, F, Joly, V, Poizot‐Martin, I, Garraffo, R, Peytavin, G, Fafi‐Kremer, S, Rey, D, Bonnet, B., Bouchez, S., Hall, N., Aubry, O., Point, P., Besnier, M., Grossi, O., Lefebvre, M., Hüe, H., Soria, A., Pineau, S., André‐Garnier, E., Rodallec, A., Brégigeon, S., Faucher, O., Orticoni, M., Soavi, M. J., Ressiot, E., Pinot, I., Ducassou, M. J., Bertone, H., Gallie, S., Ritleng, A. S., Ivanova, A., Blanco‐Betancourt, C., Alvarez, M., Biezunski, N., Debard, A., Delobel, P., Delpierre, C., Marchou, B., Martin‐Blondel, G., Mularczyk, M., Garipuy, D., Saune, K., Marcel, M., Puntis, E., Ceppi, C., Cottalorda, J., Dellamonica, P., Demonchy, E., Dunais, B., Ferrando, S., Fuzibet, J. G., Risso, K., Mondain, V., Naqvi, A., Oran, N., Perbost, I., Pillet, S., Prouvost‐Keller, B., Wehrlen‐Pugliese, S., Rosenthal, E., Roger, P. M., Vandame, S., Ajana, F., Baclet, V., Huleux, T. H., Melliez, H., Viget, N., Aissi, E., Meybeck, A., Agher, R., Katlama, C., Mackoumbou‐Nkouka, C., Louni, F., Descamps, D., Cotte, L., Peyramond, D., Chidiac, C., Ader, F., Biron, F., Boibieux, A., Miailhes, P., Perpoint, T., Dahoud, F., Lippmann, J., Koffi, J., Longuet, C., Guéripel, V., Augustin‐Normand, C., Degroodt, S., Batard, M. L., Cheneau, C., Mautort, E., Fischer, P., Partisani, M., Priester, M., Bani‐Sadr, F., Berger, J. L., Hentzien, M.

Get full text

CMV+ Serostatus Associates Negatively with CD4:CD8 Ratio Normalization in Controlled HIV-Infected Patients on cART by Poizot-Martin, Isabelle, Allavena, Clotilde, Duvivier, Claudine, Cano, Carla Eliana, Guillouet de Salvador, Francine, Rey, David, Dellamonica, Pierre, Cuzin, Lise, Cheret, Antoine, Hoen, Bruno

“…Cytomegalovirus (CMV) infection is common among HIV-infected patients but its repercussion on the course of CD4+ and CD8+ T cells after cART initiation remains…”
Get full text

Intérêt du suivi protocolisé de la surveillance vétérinaire dans un centre anti-rabique (CAR) by Morineau, P., Coutherut, J., Delbos, P., Briend-Godet, V., Lefevbre, M., Biron, C., Raffi, F.

“…Évaluer le taux de récupération des certificats vétérinaires après exposition antirabique et l’impact des relances. Étude descriptive des données…”
Get full text

Risk of diabetes in HIV‐infected patients is associated with cirrhosis but not with chronic HCV coinfection in a French nationwide HIV cohort by Provoost, A., Dramé, M., Cotte, L., Cuzin, L., Garraffo, R., Rey, D., Raffi, F., Poizot‐Martin, I., Pugliese, P., Enel, P., Obry‐Roguet, V., Faucher, O., Bregigeon, S., Ménard, A., Biezunski, N., Cuzin, L., Delobel, P., Fourcade, C., Porte, L., Mularczyk, M., Garipuy, D., Lepain, I., Marcel, M., Metsu, D., Puntis, E., Pugliese, P., Ceppi, C., Cottalorda, J., Ferrando, S., Fuzibet, J. G., Garraffo, R., Naqvi, A., Perbost, I., Pillet, S., Prouvost‐Keller, B., Pradier, C., Roger, P. M., Rosenthal, E., Dellamonica, P., Raffi, F., Bonnet, B., Brunet, C., Jovelin, T., Bernaud, C., Morineau, P., Reliquet, V., Hüe, H., Cavellec, M., Soria, A., André‐Garnier, E., Rodallec, A., Ferré, V., Leguen, L., Lefebvre, M., Jacomet, C., Cheret, A., Choisy, P., Duvivier, C., Valantin, M. A., Agher, R., Katlama, C., Isnard‐Bagnis, C., Peytavin, G., Joly, V., Yazdanpanah, Y., Cabié, A., Pierre‐François, S., Liautaud, B., Fischer, P., Cheneau, C., Priester, M., Bernard‐Henry, C., de Mautort, E., May, T., Hoen, B., Chirouze, C., Gardiennet, Q., Bani‐Sadr, F., Berger, J. L., N'Guyen, Y., Lambert, D., Lebrun, D., Kmiec, I., Brodard, V., Cotte, L., Chidiac, C., Ferry, T., Ader, F., Biron, F., Boibieux, A., Miailhes, P., Perpoint, T., Schlienger, I., Braun, E., Koffi, J., Longuet, C., Guéripel, V., Augustin‐Normand, C., Degroodt, S., Peyramond, D.

“…Summary Background Both human immunodeficiency virus (HIV) and hepatitis C virus (HCV) infections have been reportedly associated with a higher risk of…”
Get full text

Switch to Ritonavir-Boosted versus Unboosted Atazanavir plus Raltegravir Dual-Drug Therapy Leads to Similar Efficacy and Safety Outcomes in Clinical Practice by Gantner, Pierre, Bani-Sadr, Firouze, Garraffo, Rodolphe, Roger, Pierre-Marie, Treger, Michèle, Jovelin, Thomas, Pugliese, Pascal, Rey, David

“…To assess immunovirological response, safety and pharmacokinetic of NRTI-sparing regimen dual therapy of atazanavir (ATV) and raltegravir (RAL) in maintenance…”
Get full text

Hepatitis C treatment initiation in HIV-HCV coinfected patients by Cotte, Laurent, Pugliese, Pascal, Valantin, Marc-Antoine, Cuzin, Lise, Billaud, Eric, Duvivier, Claudine, Naqvi, Alissa, Cheret, Antoine, Rey, David, Pradat, Pierre, Poizot-Martin, Isabelle

“…There are few data regarding HCV treatment initiation among HIV/HCV coinfected patients. The objective of this study was to analyze the changing patterns of…”
Get full text

Characteristics and consequences of medical care interruptions in HIV-infected patients in France by CUZIN, L., DELLAMONICA, P., YAZDANPANAH, Y., BOUCHEZ, S., REY, D., HOEN, B., CABIÉ, A.

“…To describe the consequences of medical care interruptions (MCIs) we selected patients with at least two medical encounters between January 2006 and June 2013…”
Get full text

First-line cART regimen impacts the course of CD8+ T-cell counts in HIV-infected patients that achieve sustained undetectable viral load by Poizot-Martin, Isabelle, Allavena, Clotilde, Delpierre, Cyrille, Duvivier, Claudine, Obry-Roguet, Véronique, Cano, Carla E., Guillouet de Salvador, Francine, Rey, David, Dellamonica, Pierre, Cheret, Antoine, Cuzin, Lise, Katlama, Christine, Cabié, André, Hoen, Bruno

“…The aim of the study was to investigate the impact of first-line combined antiretroviral therapy (cART) regimen on the course of CD8 T-cell counts in human…”
Get full text

Comparative risk of failure of ABC/3TC or TDF/FTC based first‐line regimens in patients with a high viral load by Flandre, P, Pugliese, P, Allavena, C, Katlama, C, Cotte, L, Cheret, A, Cabié, A, Rey, D, Chirouze, C, Cuzin, L, Obry‐Roguet, V., Bregigeon, S., Poizot‐Martin, I., Marchou, B., Massip, P., Bonnet, E., Obadia, M., Alvarez, M., Porte, L., Delobel, P., Chauveau, M., Garipuy, D., Bernard, J., Lepain, I., Marcel, M., Puntis, E., Sauné, K., Ceppi, C., Cua, E., Cottalorda, J., Dellamonica, P., Demonchy, E., Durant, J., Etienne, C., Ferrando, S., Garraffo, R., Mondain, V., Oran, N., Perbost, I., Pillet, S., Prouvost‐Keller, B., Pradier, C., Wehrlen‐Pugliese, S., Sausse, S., Roger, P.M., Bernaud, C., Billaud, E., Biron, C., Bonnet, B., Bouchez, S., Boutoille, D., Hall, N., Jovelin, T., Morineau, P., Reliquet, V., Hue, H., Larmet, L., Pineau, So, Ferré, V., André‐Garnier, E., Rodallec, A., Choisy, P., Yazdanpanah, Y., Landman, R., Duvivier, C., Agher, R., Consigny, P.H., Cessot, G., Touam, F., Usubillaga, R., Benhadj, K., Abel, S., Pierre‐François, S., Ouka, M., Martial, J., Ebel, E., Cheneau, C, Priester, M, Batard, ML, Bernard‐Henry, C, Mautort, E, Drobacheff‐Thiébaut, C., Faller, J.P., Faucher, J.F., Foltzer, A., Jacomet, C., Laurichesse, H., Lesens, O., Aumeran, C., Baud, O., Beytout, J., Coban, D., Casanova, S., Rouger, C., Peyramond, D., Chidiac, C., Ader, F., Boibieux, A., Miailhes, P, Perpoint, T.

“…Objectives To compare the efficacy, in current clinical practice, of first regimens containing abacavir with lamivudine (ABC/3TC) or tenofovir with…”
Get full text

Rabid dog illegally imported to France from Morocco, August 2011 by Mailles, A, Boisseleau, D, Dacheux, L, Michalewiscz, C, Gloaguen, C, Ponçon, N, Bourhy, H, Callon, H, Vaillant, V, Dabosville, I, Morineau-Le Houssine, P

“…In August 2011, a case of canine rabies was notified to the French veterinary services. The dog was a three-month-old puppy illegally imported from Morocco…”
Get full text

Évaluation de l’acceptabilité de la vaccination contre le papillomavirus chez les hommes ayant des relations sexuelles avec des hommes infectés ou non par le VIH by Vilain, C., Sécher, S., Patoureau, M., Bouchez, S., Allavéna, C., Michau, C., Abgueguen, P., Léautez, S., Crochette, N., Morineau, P.

“…L’infection par les papillomavirus (HPV) est la plus fréquente des infections sexuellement transmissibles virales. En France, la vaccination HPV est…”
Get full text

Which antiretrovirals should be prescribed as first-line treatments? Changes over the past 10 years in France by Pugliese, P., Joly, V., Valantin, M.A., Cotte, L., Huleux, T., Allavena, C., Reynes, J., Poizot-Martin, I., Bani-Sadr, F., Cuzin, L.

“…•We aimed to describe the changes in first-line antiretroviral (ART) regimens in France between 2005 and 2015 as well as patients’ characteristics related to…”
Get full text

Existe-t-il des indicateurs pertinents pour réaliser une sérologie antirabique après traitement post-exposition à un risque rabique ? by Morineau, P., Fuchs, B., Coutherut, J., Delbos, P., Biron, C., Raffi, F.

“…Au sein de notre centre antirabique (CAR) une sérologie ELISA est indiquée après vaccination antirabique (VAR) chez les personnes immunodéprimées (ID), les…”
Get full text

Étude transversale de la couverture vaccinale (CV) dTP, grippe, pneumocoque et hépatite B des patients VIH suivis dans un service de maladies infectieuses et tropicales d’un CHU by Morineau, P., Sécher, S., Allavena, C., Hall, N., Bouchez, S., Coutherut, J., Biron, C., Raffi, F.

“…Les recommandations nationales insistent sur la mise à jour des vaccins recommandés dans le calendrier vaccinal et des vaccins grippe, pneumocoque et hépatite…”
Get full text

Twelve-year experience of nevirapine use: benefits and convenience for long-term management in a French cohort of HIV-1-infected patients by Reliquet, Véronique, Allavena, C, Morineau-Le Houssine, P, Mounoury, O, Raffi, F

“…To describe safety and long-term efficacy of nevirapine (NVP) in a real-life setting. From 1996 to 2008, among the 745 patients who received NVP, 592 were…”
Get more information

Levels and determinants of breast and cervical cancer screening uptake in HIV‐infected women compared with the general population in France by Mours, P., Sordage, M., Rabier, V., Huguet, D., Barruet, R., Chabrol, A., Jeantils, V., Hessamfar, M., Mercié, P., Paccalin, F., Pertusa, M. C., Vandenhende, M. A., Rogeaux, O., Mortier, E., Lascaux, A. S., Lelièvre, J. D., Melica, G., Buisson, M., Leprêtre, A., Brion, J. P., Pavese, P., Faba, L., Roncato‐Saberan, M., Leautez‐Nainville, S., Froguel, E., Godin‐Collet, C., Roussin‐Bretagne, S., Denes, E., Ducroix‐Roubertou, S., Boibieux, A., Miailhes, P., Chiarello, P., Dhiver, C., Madrid, A., Ménard, A., Orticoni, M., Soavi, M. J., Favier, C., Jacquet, J. M., Le Moing, V, Allavena, C., Bonnet, B., Dellamonica, P., Durant, J., Pugliese, P., Sanderson, F., Prazuck, T., Arsac, P., Ahouanto, M., Dia Kotuba, A., Jestin, C., Joly, V., Landgraf, N., Machado, M., Matheron, S., Bani‐Sadr, F., Batisse, D., Buisson, M., Derouineau, J., Gonzalez, G., Badsi, E., Bendenoun, M., Durel, A., Pichon, F., Roudière, L., Samba, M. C., Tubiana, R., Campa, P., Meyohas, M. C., Raguin, G., Balkan, S., Lafaurie, M., Pavie, J., Pintado, C., Ponscarme, D., Bonnard, P., Lebrette, M. G., Ferreyra, M., Saada, M., Perfezou, P., Bord, S., Debab, Y., Gueit, I., Feltgen, K., Joly, C., Khuong, M. A., Daoud, F., Fascia, P., Partisani, M., Priester, M., Zucman, D., Prevoteau du Clary, F., Chauveau, M., Cuzin, L., Tribonnière, X, Huleux, T., Valette, M., Viget, N., Escaut, L., Caraux‐Paz, P.

“…Objectives Cancer is a growing concern for HIV‐infected people, and screening plays a major role in alleviating the burden it causes. We sought to investigate…”
Get full text

Salvage therapy with ritonavir-boosted amprenavir/fosamprenavir: virological and immunological response in two years follow-up by Quercia, Romina, Garnier, Elisabeth, Ferré, Virginie, Morineau, Pascale, Bonnet, Bénédicte, Soulard, Claire, Raffi, François

“…To evaluate the efficacy of salvage regimens containing ritonavir-boosted amprenavir (APV/r) or fosamprenavir (FPV/r) in heavily pretreated protease inhibitor…”
Get more information

Cellular immune responses induced with dose-sparing intradermal administration of HIV vaccine to HIV-uninfected volunteers in the ANRS VAC16 trial by Launay, Odile, Durier, Christine, Desaint, Corinne, Silbermann, Benjamin, Jackson, Angela, Pialoux, Gilles, Bonnet, Bénédicte, Poizot-Martin, Isabelle, Gonzalez-Canali, Gustavo, Cuzin, Lise, Figuereido, Suzanne, Surenaud, Mathieu, Ben Hamouda, Nadine, Gahery, Hanne, Choppin, Jeannine, Salmon, Dominique, Guérin, Corinne, Bourgault Villada, Isabelle, Guillet, Jean-Gérard

“…The objective was to compare the safety and cellular immunogenicity of intradermal versus intramuscular immunization with an HIV-lipopeptide candidate vaccine…”
Get full text

Prévalence élevée des lymphomes de la zone marginale chez les patients co-infectés VIH-VHC à l’ère de la trithérapie anti-virale : cohorte ANRS CO16 Lymphovir by Terrier, B., Cacoub, P., Costagliola, D., Chavez, H., Canioni, D., Escaut, L., Letranchant, L., Morineau-Le Houssine, P., Simon, A., Taoufik, Y., Raphael, M., Besson, C.

Get full text